Women with FSHR-inactivating mutations causing resistant ovarian syndrome benefit from oocyte in-vitro maturation

Xiaofeng Li(Zhuhai People's Hospital), Fei Gong, Jinglin Zhou(Beijing University of Chemical Technology), Chaofeng Tu(Central South University), Chen Tan(Central South University), Juan Du(Central South University), Ge Lin(Mineral Resources), Wenbin He(Hunan Normal University), Ling Liu(Guangxi Normal University), Yong Li(Baylor College of Medicine), Guangxiu Lu(Hunan Normal University), Jing Hu(Central South University), Yifan Gu(Central South University), Qianjun Zhang(Central South University), Lanlan Meng(Reproductive & Genetic Hospital CITIC-Xiangya), Yue‐Qiu Tan(Central South University), Liang Hu(Zhejiang University), Yi Tang(Central South University)
Reproductive BioMedicine Online
November 20, 2024
10.1016/j.rbmo.2024.104733
Cited by 3

Related Papers

Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
|Molecular Cancer|2020|578
Circular RNAs in human cancer
|Molecular Cancer|2017|527